Australian Government Department of Health and Ageing Immunisation HandbookAustralian Government Department of Health and Ageing crest. Link to the Immunise Australia Program homepage.

2.3 Groups with special vaccination requirements

2.3.5 Vaccination of patients following receipt of other blood products including blood transfusions - updated July 2009

Please note: due to continuous updates being made to the Immunisation Handbook, the page number on the electronic version will not always match the hard copy version.

People who have received a blood transfusion, including mass blood transfusions, do not require revaccination. However, following the receipt of any blood product, including plasma or platelets, an interval of 3 to 7 months should elapse, dependent on the blood product transfused, before vaccination with an MMR, MMRV or varicella vaccine (see Table 2.3.5 Recommended intervals between either immunoglobulins or blood products and MMR, MMRV or varicella vaccination). Zoster vaccine can be given at any time before or after administration of any antibody-containing blood product (see ‘2.3.4 Vaccination of recent recipients of normal human immunoglobulin’ above).

An interval is suggested because there may be low levels of antibodies present in the blood product that may impair the immune response to the live vaccine.

Table: 2.3.5: Recommended intervals between either immunoglobulins or blood products and MMR, MMRV or varicella vaccination65


 

Route

Dose

 

IU or mL

Estimated
mg IgG/kg

Interval (months)

Blood transfusion:
Washed RBCs

IV

10 mL/kg

Negligible

0

RBCs, adenine-saline
added

IV

10 mL/kg

10

3

Packed RBCs

IV

10 mL/kg

20–60

5

Whole blood

IV

10 mL/kg

80–100

6

Cytomegalovirus immunoglobulin

IV

3 mL/kg

150

6

Hepatitis A prophylaxis
(as NHIG)

IM

0.5 mL (<25 kg)

1.0 mL (25–50 kg)

2.0 mL (>50 kg)

 

3

Hepatitis B prophylaxis
(as HBIG)

IM

100 IU

400 IU

10

3

ITP (as NHIG [Intravenous])

IV

 

400

8

ITP (as NHIG [Intravenous])

IV

 

1000

10

ITP or Kawasaki disease
(as NHIG [Intravenous])

IV

 

1600–2000

11

Measles prophylaxis (as NHIG):

Standard

Immunocompromised

 

IM

IM

(max. dose 15 mL)

0.2 mL/kg

0.5 mL/kg

 

 

5

6

Plasma or platelet products

IV

10 mL/kg

160

7

Rabies prophylaxis (as RIG)

IM

20 IU/kg

22

4

Replacement (or therapy) of immune deficiencies (as NHIG [Intravenous], various doses)

IV

 

300–400

9

Rh (D) IG (anti-D)

IM

 

 

0

Tetanus (as TIG for IM use)

IM

250 IU (given within 24 hrs of injury)

500 IU (>24 hrs after injury)

10

20

3

Varicella prophylaxis (as ZIG)

IM

200 IU (0–10 kg)

400 IU (11–30 kg)

600 IU (>30 kg)

 

5


* Zoster vaccine can be given at any time before or after administration of immunoglobulin, or any antibody-containing blood product (see Chapter 3.26, Zoster).

References


65. Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2006.
Top of page